A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2004
12/07/2004	US6828447 Therapeutic agent for use in the treatment of cardiovascular and inflammatory disorders
12/07/2004	US6828446 Aromatic thioether liver X-receptor modulators
12/07/2004	US6828445 Process for the preparation of baccatin III derivatives
12/07/2004	US6828440 Analgesics; side effect reduction
12/07/2004	US6828412 Degradable polymers
12/07/2004	US6828351 Methods and compositions for regulating memory consolidation
12/07/2004	US6828350 Inhibiting the activity of a picornavirus 3C protease or a cysteine protease with a composition having an orthohydroxy keto aryl core structure
12/07/2004	US6828349 With gamma vinylGABA or a pharmaceutically acceptable salt thereof
12/07/2004	US6828348 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same
12/07/2004	US6828347 Anti-viral multi-quinone compounds and regiospecific synthesis thereof
12/07/2004	US6828346 In mixture with alpha-tocopherol; administering by mouth
12/07/2004	US6828345 Tertiary amines such as 2-dimethylaminomethyl-1-(3-methoxy-phenyl)-6-methylcyclohexanol, used as analgesics
12/07/2004	US6828343 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
12/07/2004	US6828342 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment
12/07/2004	US6828341 Brain disorders; anticonvulsants; central nervous system disorders; psychological disorders
12/07/2004	US6828340 Especially for cancer which has developed a multidrug-resistant phenotype.
12/07/2004	US6828338 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
12/07/2004	US6828337 Bicyclic retinods containing ester or acid group; useful for treating emphysema
12/07/2004	US6828336 Nicotine-containing, controlled release composition and method
12/07/2004	US6828335 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
12/07/2004	US6828334 Having high dissolution profile and in vivo enhanced bioavailability
12/07/2004	US6828333 Ether derivatives useful as inhibitors of PDE4 isozymes
12/07/2004	US6828332 Piperidine derivatives as reuptake inhibitors
12/07/2004	US6828330 Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease
12/07/2004	US6828328 Analgesic combination of muscarinic agonists
12/07/2004	US6828327 Macroheterocylic compounds useful as kinase inhibitors
12/07/2004	US6828325 A benzoxazolopiperazine derivative useful for treating Parkinson's diseases, schizophrenia, anxiety and depression
12/07/2004	US6828324 Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT1A activity
12/07/2004	US6828323 Isoalloxazine derivatives to neutralize biological contaminants
12/07/2004	US6828322 Triazolo-pyridazine derivatives as ligands for GABA receptors
12/07/2004	US6828321 Compounds specifically radiosensitize hypoxic tumor cells
12/07/2004	US6828320 Heterocyclic compounds
12/07/2004	US6828319 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
12/07/2004	US6828318 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
12/07/2004	US6828317 Bactericides; gramnegative, grampositive bacteria
12/07/2004	US6828315 1-Amino triazoloc4,3-a! quinazoline-5-ones and/or -5-thiones inhibiting phosphodiesterase IV
12/07/2004	US6828314 Modulation of the activity of serotonin receptors (5-HT) to treat diseases such as anxiety, depression or obesity
12/07/2004	US6828313 Such as skin grafts
12/07/2004	US6828312 Therapy of mammal susceptible to, suffering from, suspected of having or recovering from a disease impacted by tissue factor(TF), by administering TF blocking compound
12/07/2004	US6828309 Use of pentosan polysulfate to treat certain conditions of the prostate
12/07/2004	US6828308 Compositions and methods for the treatment or prevention of inflammation
12/07/2004	US6828307 Obtained by Depolymerization of a Fucan From Phaeophyceae
12/07/2004	US6828306 Charged lipid compositions and methods for their use
12/07/2004	US6828301 Pharmaceutical compositions for hepatitis C viral protease inhibitors
12/07/2004	US6828155 Method for evaluating lipid a analog-containing injections
12/07/2004	US6828105 Methods of their use in inhibition of growth of viruses of the picornavirus, calicivirus, togavirus and flavivirus families, as in treatment of a viral infection. The antisense antiviral compounds are substantially uncharged oligomers having a
12/07/2004	US6828103 Genetic polymorphisms of estrogen receptor alpha associated with favorable response to hormone replacement therapy
12/07/2004	US6827951 Composition and method for smoke detoxification
12/07/2004	US6827947 Film coating
12/07/2004	US6827946 Compositions containing both sedative and non-sedative antihistamines
12/07/2004	US6827943 Comprising 21-40 wt-% urea, and trace amounts of salts of zinc, copper and manganese and the balance an excipient; treating, protecting and re-epitheliazing skin disorders; wound healing agents; semisolids; moisture; microbiocides
12/07/2004	US6827942 Composition and method of use
12/07/2004	US6827932 Activated charcoal based composition and method for reducing hangover symptoms associated with the consumption of alcohol containing beverages
12/07/2004	US6827929 Scar treatment composition
12/07/2004	US6827926 Administering a porphyrin compound that coordinates gallium in the central pyrrolic core, and irradiating porphyrin compound with energy at a wavelength capable of exciting the molecule to achieve the desired detection or therapeutic effect
12/07/2004	CA2382262C A nutritional supplement for lowering serum triglyceride and cholesterol levels
12/07/2004	CA2352332C Hygromycin a derivatives
12/07/2004	CA2316921C Aryl fused azapolycyclic compounds
12/07/2004	CA2287736C Furopyridine antibacterials
12/07/2004	CA2272136C Pyrazole derivatives having crf antagonist activity
12/07/2004	CA2208673C Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin
12/07/2004	CA2158834C Antisense oligos which interfere with mrna cap activity and inhibit translation
12/07/2004	CA2154668C Condensed heterocyclic glutamic acid derivatives as antiproliferative agents
12/07/2004	CA2150123C Aminomethylene substituted non-aromatic heterocycles
12/07/2004	CA2147755C 6-(substituted methylene) penems and intermediates
12/07/2004	CA2127374C Novel derivative of isoindolinone, its preparation and pharmaceutical compositions containing it
12/07/2004	CA2112331C Novel naphthalene derivatives
12/07/2004	CA2108817C Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing these compounds and their use, and processes for their preparation
12/07/2004	CA2105251C Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor
12/02/2004	WO2004104217A2 Protein kinase c zeta as a drug target for arthritis and other inflammatory diseases
12/02/2004	WO2004104199A2 Modulation of gene expression using dna-dna hybrids
12/02/2004	WO2004104054A1 Poly and copoly (n-vinylamide)s and their use in capillary electrophoresis
12/02/2004	WO2004104022A2 Compositions comprising pathogen elicited epithelial chemoattractant (eicosanoid hepoxilin a3), inhibitors thereof and methods of use thereof
12/02/2004	WO2004104018A2 Compositions for delivering peptide yy and pyy agonists
12/02/2004	WO2004104010A1 Crystalline form of cefdinir
12/02/2004	WO2004104007A1 Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors
12/02/2004	WO2004104005A2 Immunosuppressive effects of pteridine derivatives
12/02/2004	WO2004104003A1 Novel pyridopyrazines and use thereof as kinase modulators
12/02/2004	WO2004104002A1 Novel pyridopyrazines and use thereof as kinase inhibitors
12/02/2004	WO2004103996A1 Hepatitis c inhibitor compounds
12/02/2004	WO2004103995A1 N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors
12/02/2004	WO2004103987A1 Drug for nervous disorder
12/02/2004	WO2004103986A2 3-desoxyanthocyanidine compounds and uses thereof as antimicrobial agents
12/02/2004	WO2004103982A1 2-[2-[4-[(4-chlorophenyl) phenylmethyl]-1-piperazinyl]ethoxy]acetic acid monohydrochloride as anti-allergenic compound and process for its production
12/02/2004	WO2004103980A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i
12/02/2004	WO2004103974A1 Substituted 2-oxoquinoline compound and medicinal use thereof
12/02/2004	WO2004103973A1 Phenyl quinolines and their use as estrogen receptor modulators
12/02/2004	WO2004103961A2 Sulfated bis-cyclic agents
12/02/2004	WO2004103960A2 Compounds and uses thereof
12/02/2004	WO2004103959A2 Heterocyclic compounds and uses thereof
12/02/2004	WO2004103411A1 Migraine remedy
12/02/2004	WO2004103410A1 Methods compositions and articles of manufacture for modulating bone growth
12/02/2004	WO2004103407A2 Composition comprising a pde4 inhibitor and a pde5 inhibitor
12/02/2004	WO2004103406A1 Therapeutic composition for disease accompanied by decrease or increase of platelet
12/02/2004	WO2004103394A2 Method and compositions for nerve regeneration
12/02/2004	WO2004103389A2 Means for preventing and treating cellular death and their biological applications
12/02/2004	WO2004103387A1 The uses of bamboo leaf total flavones for the preparation of medicaments and health foods for preventing and treating for prostate diseases
12/02/2004	WO2004103386A1 New use of baicalin for treating anxiety
12/02/2004	WO2004103383A1 A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein
12/02/2004	WO2004103382A1 Combination chemotherapy comprising 5-fluorouracil or a derivative thereof and a liposomal platinum complex

1 ... 4869 4870 4871 4872 4873 4874 4875 4876 4877 4878 4879 4880 4881 4882 4883 4884 4885 4886 4887 4888 4889 ... 7860